Status:

WITHDRAWN

Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Hematopoietic and Lymphoid Cell Neoplasm

Eligibility:

All Genders

18-39 years

Phase:

NA

Brief Summary

This pilot trial studies how well a psycho-educational program called Emerging from the Haze works in helping patients with blood and lymph cancer. Sometimes, patients who have undergone treatment for...

Detailed Description

PRIMARY OBJECTIVES: I. Demonstrate feasibility and acceptability for young adult survivors of various cancers utilizing Emerging from the Haze program. SECONDARY OBJECTIVES: I. Describe, summarize ...

Eligibility Criteria

Inclusion

  • A diagnosis of a hematological malignancy.
  • Having received chemotherapy with or without radiation therapy.
  • Physician approval.
  • Functional Assessment of Cancer Therapy-Cognition (FACT-COG) score \< 59 on the perceived cognitive impairments (PCI) subscale.
  • Eligible after 2 months (60 +/- 5 days) of completing all their active cancer treatment with the exception of patients that are post-transplant.
  • Subjective complaint of cognitive concerns at time of enrollment.
  • Must be able to understand and communicate proficiently in English.
  • Ability to understand and the willingness to sign a written informed consent.
  • Agree to complete study surveys.

Exclusion

  • Patients who have significant personality disorders or unstable psychiatric disorders as assessed by the interviewing clinician.
  • Patients with known brain metastases, history of brain metastases or radiation to the brain.
  • Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction.
  • Non-English speaking patients.

Key Trial Info

Start Date :

February 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 10 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03804164

Start Date

February 10 2020

End Date

February 10 2020

Last Update

December 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

City of Hope Medical Center

Duarte, California, United States, 91010